Compounds > 4-methoxyamphetamine
Page last updated: 2024-08-23

4-methoxyamphetamine and beta-Thalassemia

4-methoxyamphetamine has been researched along with beta-Thalassemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koussa, S; Maakaron, JE; Matta, BN; Musallam, KM; Taher, AT1
Berdoukas, V; Chouliaras, G; Ladis, V; Yiannoutsos, CT1
Berdoukas, V; Berdoussi, E; Chouliaras, G; Kattamis, C; Ladis, V; Moraitis, P; Zannikos, K1
Abdin, IA; Ebeid, FS; El Safy, UR; Elalfy, MS; Ibrahim, AS; Salem, DS1
Berdoukas, V; Chatziliami, A; Chouliaras, G; Fragodimitri, C; Karabatsos, F; Karagiorga-Lagana, M; Kattamis, A; Ladis, V; Youssef, J1
Efthimiadis, GK; Giannakoulas, GA; Hassapopoulou, HP; Karvounis, HI; Louridas, GE; Parharidis, GE; Tsikaderis, DD1

Other Studies

6 other study(ies) available for 4-methoxyamphetamine and beta-Thalassemia

ArticleYear
A killer revealed: 10-year experience with beta-thalassemia intermedia.
    Hematology (Amsterdam, Netherlands), 2014, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Aged; Anemia; beta-Thalassemia; Child; Child, Preschool; Cross-Sectional Studies; Death; Heart Diseases; Humans; Infant; Iron Overload; Lebanon; Male; Middle Aged; Risk Factors; Young Adult

2014
Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit.
    European journal of haematology, 2009, Volume: 82, Issue:5

    Topics: Age Factors; beta-Thalassemia; Death; Female; Greece; Heart Diseases; Hemosiderosis; Humans; Male; Risk Factors; Sex Factors; Survival Analysis; Time Factors

2009
Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.
    European journal of haematology, 2010, Volume: 85, Issue:4

    Topics: Adolescent; Adult; Age Factors; Benzoates; beta-Thalassemia; Child; Death; Deferasirox; Deferiprone; Deferoxamine; Female; Greece; Heart Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Magnetic Resonance Spectroscopy; Male; Pyridones; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult

2010
Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Adolescent; Age Factors; Benzoates; beta-Thalassemia; Child; Child, Preschool; Death; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Egypt; Electrocardiography; Female; Ferritins; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Pyridones; Sex Factors; Siderophores; Siderosis; Triazoles

2010
Impact of magnetic resonance imaging on cardiac mortality in thalassemia major.
    Journal of magnetic resonance imaging : JMRI, 2011, Volume: 34, Issue:1

    Topics: Adult; beta-Thalassemia; Blood Transfusion; Chelating Agents; Death; Heart; Humans; Iron; Iron Overload; Magnetic Resonance Imaging; Myocardium; Proportional Hazards Models; Regression Analysis; Risk; Treatment Outcome

2011
Survival in thalassaemia major patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:8

    Topics: Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Death; Deferoxamine; Echocardiography, Doppler; Female; Humans; Longitudinal Studies; Male; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Siderophores; Survival Analysis; Survival Rate; Ventricular Dysfunction, Left

2006